Maria De Santis, MD: Side Effects in Young Adults with Cancer Later in Life

The Group Room at the 2012 European Society for Medical Oncology (ESMO) Congress in Vienna was made possible, in part, by:

Daiichi-Sankyo  - EPS Full Color Lilly logo

VIDEO TRANSCRIPT

Selma Schimmel, Founder & CEO, Vital Options International

This is Selma Schimmel for The Group Room at the ESMO 2012 Congress happening now in Vienna.  And, I’m happy to introduce you to Dr. Maria De Santis who is the Director of the Genitourinary Program at the Kaiser Franz Josef Hospital here in Vienna and Chair of the ESMO GU Non-Prostate Task Force.  Welcome to The Group Room Program.

Maria De Santis, MD: Kaiser Franz Josef Hospital, Vienna

I thank you for the kind invitation.  I’m happy to be here.

Selma Schimmel, Founder & CEO, Vital Options International

Young adults present unique challenges.  What are some of those challenges that you deal with as a practitioner dealing with this young adult age group?

Maria De Santis, MD: Kaiser Franz Josef Hospital, Vienna

Well, this is very much true, it is a challenge.  And it is a challenge because these patients, these young men are in the middle of their life, their working life, they are building up their families at the time point when this disease, this cancer occurs.  So, they are in a very special situation in their life and this is one of the challenges because they have a risk of losing their job with being months off their work on chemotherapy.  And, there is also sometimes a problem with the support of their families.  It is a really big burden for the patients and their families to go through all this.  Yes, and, in addition, it is, on the one hand, a highly curable disease, but on the other hand those cured patients are at risk to experience and to have long term side effects from their treatment.  And, this, I think, is a very important part of research, also, to discover those long term side effects and to try to make them or to have them become as minimal as possible.

Selma Schimmel, Founder & CEO, Vital Options International

Do you think you could reference some of what those long term effects might be?

Maria De Santis, MD: Kaiser Franz Josef Hospital, Vienna

Well, long term effects concern the nerves, polyneuropathy, is one of those long term effects.  Then, cardiovascular diseases after cisplatin-combination chemotherapy is a very important topic.  The increase of body mass index and all the following potential risks for diabetes, for hyperlipidemia, etc.; this is a problem and there are many more.

Selma Schimmel, Founder & CEO, Vital Options International

Are provisions taken easily in Europe to help young men bank their sperm before they begin treatment?

Maria De Santis, MD: Kaiser Franz Josef Hospital, Vienna

Well, at least in my country it is then that to inform the patient that sperm banking is possible, that we recommend it in certain situations.  And, many of those patients actually consider sperm banking.  And, it is especially important for those patients where we expect more than three to four courses of cisplatin-containing chemotherapy, the intermediate and poorest patients, for example.

Selma Schimmel, Founder & CEO, Vital Options International

Thank you, Dr. Maria De Santis, Director of the Genitourinary Program at the Kaiser Franz Josef Hospital here in Vienna and Chair of the ESMO GU Non-Prostate Task Force.

Maria De Santis, MD: Kaiser Franz Josef Hospital, Vienna

Thank you for the kind invitation.

END OF VIDEO

Comments